<img height="1" width="1" style="display:none" src="https://q.quora.com/_/ad/33f0fcb02bbd41af9d706a2c469929f2/pixel?tag=ViewContent&amp;noscript=1">

Testing the Future of Healthcare Interoperability

by Antony Edwards, on 11/12/19

In a recent joint announcement from Amazon, Google, IBM, Microsoft, Oracle and Salesforce, the companies stated, “The healthcare industry is at a turning point. Patients and providers are eager for advances in value-based care, patient engagement, and machine learning as they look to usher in a new era of constantly-improving health outcomes and well-being. Interoperability is key to removing the barriers between the healthcare industry and the future it seeks to build.” 

These technology giants are not alone in advocating for healthcare interoperability; the global market for these solutions 
is projected to reach $4.2 billion by 2024 with key drivers including the need to curb healthcare costs, government regulations designed to enhance patient care and safety, and the growing focus on patient-centric care.  


In order for interoperability initiatives to be successful, it’s essential that solution providers and healthcare organizations not overlook the role of testing. With software involved in every facet of a hospital visit—from the moment a patient is admitted through to diagnosis, treatment, prescription and discharge—testing this complex, interconnected environment can seem like a tall order. But with life or death healthcare decisions hinging on the performance and reliability of digital healthcare systems, organizations simply have no choice but to get it right.  


That’s where Eggplant comes in. We work with leading healthcare institutions like the Cleveland Clinic, UNC Health Care and Oxford University Hospitals, as well as health information technology companies like Cerner and Epic, to ensure that mission-critical healthcare technology functions optimally and works as intended when connected to the myriad other systems in the modern healthcare setting.  


Our Digital Automation Intelligence (DAI) Suite provides AI-driven continuous intelligent test automation, enabling healthcare companies to expand automation beyond test execution to the full testing process. This allows them to spot and address bugs, compatibility issues, accessibility problems and other factors that could lead to an outage or performance challenges long before they have the chance to impact the delivery of care. And while ensuring high-quality patient care is certainly the top priority for all of our healthcare customers, Eggplant also helps companies address additional industry-specific requirements.  


For example, privacy is a perennial concern for all healthcare industry stakeholders with new regulations issued on an ongoing basis and hefty fines levied against those not in compliance. Eggplant is uniquely suited to address these essential privacy concerns because we are the industry’s only completely non-invasive testing tool, which means our technology sits outside of the application and provides comprehensive test coverage without having to understand the nature of what is being tested. Our Robotic Process Automation (RPA) solution also offers privacy benefits and drives further gains in the form of reducing errors and freeing up human testers to focus on more strategic initiatives.  


The letter from Amazon et al states, “We believe it is important to work with stakeholders across the ecosystem—patients, providers, insurers, researchers, tech providers—to unlock important data and enable patients and their care teams to derive insights when it is needed most.” 


Learn more about Eggplant and why AI-driven test automation is key to achieving the interoperability benefits outlined above. 


Topics:HealthcareTest automationPerformance testingcontinuous testingRPA

Subscribe To Updates